Prosecution Insights
Last updated: October 02, 2026

Examiner: MARSH, OWEN LEWIS

Tech Center 3700 • Art Units: 3771 3794 3796

This examiner grants 67% of resolved cases

Analysis

Owen Lewis Marsh has resolved 3 cases in Art Unit 3771 of Tech Center 3700. His allowance rate is 66.7 percent. This percentage is a primary metric for practitioners to consider when evaluating the examiner's history. The data also shows an interview lift of 50.0 percent. This 50.0 percent lift indicates the change in allowance probability associated with an interview.

The median days to allowance is 780. This 780-day figure represents the duration of the prosecution process for the resolved cases. Practitioners should consider the 3 cases as the current record of the examiner's work. The 66.7 percent allowance rate and 50.0 percent interview lift are components of the examination profile. The median pendency is a factor for managing client expectations.

Direct communication is a documented tactic, as shown by the lift. Applicants should review the allowance rate as they prepare their prosecution strategy. The cases provide a data set for understanding the examiner's approach in Tech Center 3700. The timeline is a measure of the time required to navigate Art Unit 3771 to a successful conclusion.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

66.7%
Allow Rate
-3.3% vs TC avg
37
Total Applications
+50.0%
Interview Lift
780
Avg Prosecution Days
Based on 3 resolved cases, 2023–2026

Rejection Statute Breakdown

10.9%
§101 Eligibility
21.8%
§102 Novelty
41.1%
§103 Obviousness
24.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19023769 MEDICAL DEVICE AND METHODS OF USE Non-Final OA Boston Scientific Scimed, Inc.
18884529 CIRCULATORY SUPPORT DEVICES, SYSTEMS, AND METHODS Non-Final OA Boston Scientific Scimed, Inc.
19044030 Deep Brain Stimulation Neuromodulation Targeting Non-Final OA Boston Scientific Neuromodulation Corporation
18915053 Use of Brain Anatomical Features to Optimize Deep Brain Stimulation Final Rejection Boston Scientific Neuromodulation Corporation
18909601 SYSTEMS AND METHODS FOR MODULATING THE NEUROIMMUNE SYSTEM Non-Final OA Boston Scientific Neuromodulation Corporation
18763676 SYSTEMS AND METHODS FOR SELECTING ELECTRODES AND PROVIDING STIMULATION Non-Final OA Boston Scientific Neuromodulation Corporation
18997930 WEARABLE DEVICE FOR REGAINING SIMULTANEOUS EYELID CLOSURE FOR VICTIMS OF PARTIAL FACIAL PARALYSIS VIA DIRECT STIMULATION Non-Final OA Georgia Tech Research Corporation
18992596 DIRECTABLE LASER CATHETER SONIC WAVE WITH FOCUSING CHAMBER Non-Final OA KONINKLIJKE PHILIPS N.V.
18976395 SENSOR GEOMETRY FOR A WEARABLE DEVICE Non-Final OA Oura Health Oy
18661985 TECHNIQUES FOR UTILIZING A MULTI-OUTPUT NEURAL NETWORK Non-Final OA Oura Health Oy
18844091 DRIVE DEVICE, SURGICAL TOOL DEVICE, ARM DEVICE, AND MASTER-SLAVE SYSTEM Non-Final OA SONY GROUP CORPORATION
18715213 Smart ICM ECG Filtering Final Rejection BIOTRONIK SE & Co. KG
19013563 SYSTEMS AND METHODS OF DETERMINING LOCATION USING A MEDICAL DEVICE Non-Final OA ZOLL Medical Corporation
18849671 REMOTE ARRHYTHMIA DETECTION AND TREATMENT ANALYSIS IN WEARABLE CARDIAC DEVICES Non-Final OA ZOLL Medical Corporation
18871713 IMPLANTABLE MEDICAL LEAD IMPLANT TOOL Non-Final OA Medtronic, Inc.
18294496 ELECTRODES FOR NEUROMODULATION Final Rejection Cala Health, Inc.
19029261 TRANSVASCULAR NERVE STIMULATION APPARATUS AND METHODS Non-Final OA Lungpacer Medical Inc.
18987416 LASER PHACOLYSIS SYSTEM AND METHOD Non-Final OA UNIVERSITY OF SOUTH FLORIDA
18635292 DELIVERY TUBE WITH BRAID Non-Final OA MAGENTA MEDICAL LTD
18693859 Methods and Apparatuses for Determination of Hot Flashes Non-Final OA 1625986 ONTARIO LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month